314 related articles for article (PubMed ID: 17548505)
1. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
2. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
6. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Iino M; Iizuka C
Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT Findings in a Patient With Neurosarcoidosis.
Chen X; Chen G; Fu Z; Li Q
Clin Nucl Med; 2020 Aug; 45(8):640-641. PubMed ID: 32520495
[TBL] [Abstract][Full Text] [Related]
8. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
Imperiale A; Riehm S; Braun JJ
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):177-86. PubMed ID: 23598684
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.
Sobic-Saranovic DP; Grozdic IT; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko VM; Saranovic DZ; Pavlovic SV; Obradovic VB
Clin Nucl Med; 2013 Jul; 38(7):516-21. PubMed ID: 23486337
[TBL] [Abstract][Full Text] [Related]
10. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
Ng D; Jacobs M; Mantil J
Clin Nucl Med; 2006 Jul; 31(7):373-5. PubMed ID: 16785800
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
12. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
Ito K; Miyata Y; Minamimoto R; Kubota K
Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
[TBL] [Abstract][Full Text] [Related]
13. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
14. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT.
Khodarahmi I; Turbin RE; Frohman LP; Ghesani N
Clin Nucl Med; 2016 Sep; 41(9):e410-1. PubMed ID: 27454591
[TBL] [Abstract][Full Text] [Related]
16. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
17.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT imaging of extensive systemic sarcoidosis with epididymal involvement.
Aga F; Yamamoto Y; Tanaka K; Ono Y; Dobashi H; Nishiyama Y
Clin Nucl Med; 2013 Jan; 38(1):63-4. PubMed ID: 23242053
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
Miller CT; Sweiss NJ; Lu Y
Clin Nucl Med; 2016 May; 41(5):417-8. PubMed ID: 26828145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]